-
Galena Biopharma 2016 Outlook Focuses On 'High Value' Cancer Immunotherapy Pipeline
Wednesday, January 13, 2016 - 2:37pm | 263Shares of Galena Biopharma Inc (NASDAQ: GALE) were trading lower by more than 5 percent at $0.770 on Wednesday after the company detailed its 2016 strategy. Galena Biopharma noted that its 2016 strategy to advance the company's "high value" cancer immunotherapy clinical...